| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie is experiencing robust growth in its product development, especially in immunology, highlighted by strong sales of its therapies such as Rinvoq and Skyrizi. Recent FDA approvals, including RINVOQ for giant cell arteritis, further showcase the company's commitment to advancing its product offerings. Innovative treatment developments indicate a promising outlook for AbbVie's future in the biopharmaceutical sector. Overall, the successes in product lines and strong market reception contribute positively to AbbVie's growth strategy. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.2 on 2025-04-29. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-29 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2025-04-28 | 0%(0%) | 0 | 0% | 0.2 | 1.9 | -1 | |||||||
| 2025-04-27 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-04-26 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-25 | 0%(0%) | 0 | 0% | -0.5 | -2.2 | -1 | |||||||
| 2025-04-24 | 0%(0%) | 0 | 0% | -0.8 | -3.8 | -1 | |||||||
| 2025-04-23 | 0%(0%) | 0 | 0% | -0.9 | -4.3 | -1 | |||||||
| 2025-04-22 | 0%(0%) | 0 | 0% | -0.9 | -4.2 | -1 | |||||||
| 2025-04-21 | 0%(0%) | 0 | 0% | -0.9 | -4.3 | -1 | |||||||
| 2025-04-20 | 0%(0%) | 0 | 0% | -0.7 | -3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-06-11 22:40:35 Insights from financial experts on final trades provide analysis and recommendations, impacting investor decisions and perceptions of specific stocks. |
| 2025-06-11 22:40:35 The articles reflect a growing investor interest in certain stocks, particularly AbbVie, with implications for broader market trends and investor behavior. |
| 2025-06-11 22:40:35 The approval of RINVOQ by the FDA for treating giant cell arteritis signifies strong progress in AbbVie's product offerings and development strategy. |
| 2025-06-11 22:40:35 AbbVie's stock is frequently discussed in relation to its recent trading performance, with mixed opinions on its sustainability and future trends. |
| 2025-06-11 22:40:35 Several articles focus on class action lawsuits related to investments in companies like Cerevel Therapeutics, highlighting concerns over securities fraud. |